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Abstract
Introduction: Critically ill patients with diabetes are at increased risk for the development of complications, but
the impact of diabetes on mortality is unclear. We conducted a systematic review and meta-analysis to determine
the effect of diabetes on mortality in critically ill patients, making a distinction between different ICU types.
Methods: We performed an electronic search of MEDLINE and Embase for studies published from May 2005 to
May 2010 that reported the mortality of adult ICU patients. Two reviewers independently screened the resultant
3,220 publications for information regarding ICU, in-hospital or 30-day mortality of patients with or without
diabetes. The number of deaths among patients with or without diabetes and/or mortality risk associated with
diabetes was extracted. When only crude survival data were provided, odds ratios (ORs) and standard errors were
calculated. Data were synthesized using inverse variance with ORs as the effect measure. A random effects model
was used because of anticipated heterogeneity.
Results: We included 141 studies comprising 12,489,574 patients, including 2,705,624 deaths (21.7%). Of these
patients, at least 2,327,178 (18.6%) had diabetes. Overall, no association between the presence of diabetes and
mortality risk was found. Analysis by ICU type revealed a significant disadvantage for patients with diabetes for all
mortality definitions when admitted to the surgical ICU (ICU mortality: OR [95% confidence interval] 1.48 [1.04 to
2.11]; in-hospital mortality: 1.59 [1.28 to 1.97]; 30-day mortality: 1.62 [1.13 to 2.34]). In medical and mixed ICUs, no
effect of diabetes on all outcomes was found. Sensitivity analysis showed that the disadvantage in the diabetic
surgical population was attributable to cardiac surgery patients (1.77 [1.45 to 2.16], P < 0.00001) and not to general
surgery patients (1.21 [0.96 to 1.53], P = 0.11).
Conclusions: Our meta-analysis shows that diabetes is not associated with increased mortality risk in any ICU
population except cardiac surgery patients.
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Introduction
The proportion of patients with diabetes admitted to the
I C Ui sg r o w i n ga sar e s u l to ft h ew o r l d w i d ei n c r e a s ei n
type 2 diabetes. In cardiac surgery patients, the growth is
even more pronounced, since patients with diabetes-
associated, often complex, multivessel macrovascular
complications are preferably treated surgically rather
than by percutaneous intervention [1,2]. It is known that
diabetic patients admitted t ot h eI C Ua r em o r ep r o n et o
develop complications [3-5], at least in part because of
hampered immune cell function associated with the
disease [6,7]. One would expect an increased mortality
rate for diabetic ICU patients, but the literature at this
point is conflicting, with reports of increased, equal or
even decreased mortality rates among this population
compared to patients without diabetes. Also, there might
be a difference in outcomes between various ICU popula-
tions, such as cardiac surgery and medical patients.
To better understand the role of diabetes in critical ill-
ness, we conducted a systematic review and meta-analysis
of studies regarding mortality, including observational as
well as intervention studies that reported ICU, in-hospital
and/or 30-day mortality rates of ICU-admitted patients
with diabetes.
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This study was conducted according to the recommen-
dations of the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) group [8]. The study did not
need ethical approval, since it was a retrospective analy-
sis of anonymous data.
Data sources and search strategy
Together with the clinical librarian at our institution, an
electronic search of MEDLINE and Embase from 1 May
2005 to 1 May 2010 was performed for studies that
reported mortality of adult ICU patients, including both
retrospective and prospective studies and both observa-
tional and intervention studies. The five-year limit was
chosen because we expected that insulin treatment regi-
mens and other therapies would be comparable among
studies in this rapidly evolving field. The text terms and
medical subheading, or MeSH, terms ‘intensive care unit’,
‘critical care’ and ‘mortality’ were combined. Since a preli-
minary search showed that diabetes was not always the
primary interest of included studies, and to prevent publi-
cation bias, we narrowed the search by not using ‘diabetes
mellitus’ as a search term. To avoid possible treatment-
induced bias, randomized controlled trials comparing
intensive insulin therapy regimes were excluded [9]. We
limited our search to research performed in adult human
patient populations and published in the English-language
literature. Unpublished studies were not identified.
Study selection
Two reviewers (SES and MH) independently screened the
records. Agreement on final inclusion was reached by con-
sensus. Inclusion and exclusion criteria were defined a
priori. A study was included if it reported crude ICU, in-
hospital and/or 30-day mortality of ICU-admitted patients
with or without diabetes and/or included univariate or
multivariate analysis of mortality risk for diabetic patients
represented as odds ratios (ORs), hazard ratios or relative
risks. Studies reporting 28- or 30-day mortality rates were
combined. We excluded studies in which diabetes was the
reason for ICU admittance, that is, ketoacidosis, as well as
studies concerning patients with gestational diabetes and
ICU readmissions. When it was not possible to obtain the
full paper from our institutional library or the Internet, the
corresponding author was contacted if the population
included in the study was larger than 500 patients.
Data extraction
From the included publications the following data were
extracted: first author, year of publication, country where
the work was performed, study design, type of ICU,
population specification, reported mortality type, defini-
tion of diabetes and the numbers of patients with and
without diabetes. Subsequently, the number of deaths
among patients with or without diabetes and/or the
mortality risk associated with the presence of diabetes
were extrapolated. We contacted the corresponding
author for additional information when the publication
reported only a P v a l u ef o rm o r t a l i t yr i s ko rw h e nt h e
exact number or proportion of patients with diabetes was
not reported.
Study quality
No individual assessment of study quality was performed.
Funnel plot analysis did not suggest any publication bias.
We did not expect bias in outcome reporting, because
death is a robust end point, and it is unlikely that patients
were lost to follow-up, as the primary outcome was
recorded in the hospital.
Data synthesis and statistical methods
The meta-analysis was performed using RevMan version 5
software (The Cochrane Collaboration, Oxford, UK). Ana-
lyses were performed separately for ICU, in-hospital and
30-day mortality as outcome variables. Data were synthe-
sized using inverse variance with ORs as the effect mea-
sure. In the primary analysis, unadjusted results were used
where possible. If only crude mortality data were provided,
then the ORs and standard errors were calculated. An OR
> 1 suggested that diabetes was associated with an
increased risk of death. We stratified the analyses by ICU
type: trauma, surgical, medical and mixed. Data were
pooled using a random effects model because heterogene-
ity between studies was anticipated. Heterogeneity was
assessed using the I
2 statistic.
We performed sensitivity analyses to explore the
robustness of the data and the influence of the following
factors on effect size by repeating the analysis: (1) using a
fixed instead of a random model, (2) leaving out the two
largest studies, (3) making distinctions between cardiac
and other types of surgery, (4) selecting and pooling only
the five studies reporting unadjusted as well as adjusted
outcomes and comparing these two effect sizes to assess
the possible influence of confounders and (5) using
adjusted instead of unadjusted effect sizes of those five
studies in the in-hospital mortality analysis.
Results
Figure 1 summarizes the study identification and selec-
tion process. After removal of duplicates derived from
t h eE m b a s ea n dM E D L I N Es e a r c h e s ,3 , 2 2 0p o t e n t i a l l y
interesting records were identified. Of these, we excluded
556 publications by reviewing the abstracts. After review
of 2,664 full articles, 2,520 were excluded: 1,814 because
no data at all were available regarding diabetes, 579
because mortality data were not available, 35 because
they reported only long-term mortality and 2 duplicate
publications were identified. We were not able to obtain
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14 reported a sample size of more than 500 participants.
Three records were excluded by data extraction because
only a P value for mortality was reported and, after con-
tacting the authors, the raw data could not be retrieved
[10-12]. Finally, 141 studies could be included in the ana-
lysis of ICU mortality (n = 50 [13-62]), in-hospital mor-
tality (n = 74 [26,63-135]) and 30-day mortality (n =2 0
[65,128,136-153]). Three studies reported results of two
outcome types: one comprised both ICU and in-hospital
mortality [26] and two comprised both in-hospital and
30-day mortality [65,128]. Only a few studies specified
the type of diabetes of the patients included (n =2 6 ) .I n
most of these studies, diabetes was defined by the use of
glucose-lowering drugs. A table listing the patient char-
acteristics in the 141 included studies is presented in
Additional file 1.
ICU mortality
The analysis of ICU mortality contained 52,908 patients,
including 7,576 deaths (Figure 2). Of those patients, at
least 8,852 were diagnosed with diabetes (16.7%). In two
studies, the number of patients with diabetes could not be
retrieved [59,62]. Overall, pooling of the data showed no
survival advantage for either group (OR 1.03, 95% confi-
dence interval (95% CI) 0.87 to 1.22, P =0 . 7 4 ,I
2 =6 4 % ) .
Analysis by ICU type showed that in the surgical ICU,
patients without diabetes did have a survival advantage
3505 records identified:
*MEDLINE: 2688 
*EMBASE: 817
2664
556 excluded by review of abstract
285 duplicates
3220
2520 excluded by review of full article: 
*DM not reported at all: 1814 
*DM mortality not reported: 579 
*Solely long-term mortality: 35 
*Secondary publication: 2 
*No full text available: 90 
141 included for data analysis: 
144
3 excluded by data extraction: 
*Only p-value reported 
*ICU mortality: 50 
*Hospital mortality: 74 
*30-day mortality: 20 
Figure 1 Study selection algorithm.
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P =0 . 0 3 ,I
2 = 0%) No differences were observed in the
trauma, medical and mixed ICUs. Overall mortality was
26.3% in general and/or cardiac surgical ICUs, 12.2% in
trauma ICUs, 35.9% in medical ICUs and 11.8% in mixed
ICUs.
Figure 2 ICU mortality. Forest plots showing odds ratios (ORs) and 95% confidence intervals (95% CIs) of ICU mortality risk for patients with or
without diabetes. The ‘0’ indicating the number of diabetic or nondiabetic patients means the information was not available. SE: standard error.
IV: inverse variance.
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The largest cohort could be analysed for in-hospital mor-
tality: 12,403,355 patients (mortality rate 21.7%), of
whom 2,313,466 patients (18.7%) had diabetes (Figure 3).
Pooling of all data did show a small mortality increase
among the patients with diabetes (OR 1.08, 95% CI 1.00
to 1.15, P = 0.04, I
2 = 70%). The disadvantage for patients
with diabetes was attributable to the effect in the surgical
patients (OR 1.59, 95% CI 1.28 to 1.97, P < 0.0001, I
2 =
56%) and trauma patients (OR 1.23, 95% CI 1.12 to 1.36,
P < 0.0001, I
2 = 0%) after stratifying by ICU type. In the
medical and mixed ICUs, no difference in outcomes
between the groups was seen. Overall mortality was 3.8%
in surgical ICUs, 5.1% in trauma ICUs, 24.2% in medical
ICUs and 9.8% in mixed ICUs.
Thirty-day mortality
A total of 4,860 patients (25.5%) with diabetes and 14,180
patients without diabetes were included in this analysis
(Figure 4). For one study that included 14,271 patients, the
proportions of patients with or without diabetes could not
be retrieved [152]. Overall, there were no differences in
mortality between the patients with or without diabetes
(OR 1.19, 95% CI 0.96 to 1.47, P =0 . 1 0 ,I
2 = 65%). Stratify-
ing the data for ICU type showed a difference in mortality
favouring the patients without diabetes in the surgical ICU
(OR 1.62, 95% CI 1.13 to 2.34, P = 0.009, I
2 = 54%). Out-
comes did not differ between groups in the medical and
mixed ICUs. No separate analysis of trauma patients could
be performed, since none of the studies reported 30-day
mortality outcomes in a trauma ICU. Overall mortality
was 2.5% in surgical ICUs, 34.6% in medical ICUs and
26.9% in mixed ICUs.
Sensitivity analyses
For ICU and 30-day mortality, the effect pointed in the
same direction when using a fixed instead of a random
model. No benefit was observed for patients with or with-
out diabetes in the trauma ICUs, medical ICUs and mixed
ICUs, but there was a significant disadvantage for surgical
patients with diabetes. Regarding in-hospital mortality, the
effect in the mixed and medical ICUs shifted towards an
advantage for diabetes patients (medical: OR 0.89 [95% CI
0.85 to 0.92], P < 0.00001; OR mixed: 0.90 [95% CI 0.88 to
0.92], P < 0.00001). This effect was attributable to the
weight of two very large studies. The medical ICU popula-
tion in the study of Martin and colleagues [101] had an
overall weight of 17.5%; The mixed ICU population in the
study of Graham and colleagues [26] had an overall weight
of 69.9%. Performing the fixed analysis without these two
large studies resulted in the same conclusions as the ran-
dom analysis, namely, no effect.
For all outcomes, we observed a mortality benefit for
nondiabetic subjects in the surgical ICU. This population
consisted of cardiac surgery patients as well as general
surgery patients, who are quite distinct regarding the
aetiology of their underlying disease compared to other
ICU populations. We performed a sensitivity analysis to
investigate whether the effect of diabetes might be differ-
ent for cardiac surgery patients vs. general surgery
patients. Since the effect was the same for ICU-, in-hospi-
tal and 30-day mortality outcomes and to increase power,
we performed the sensitivity analysis by combining all
studies of surgical ICU patients, regardless of mortality
definition. This analysis showed that the increased mor-
tality of patients with diabetes in the surgical ICU was
mainly attributable to the 21 studies including cardiac
surgery patients (OR 1.77, 95% CI 1.45 to 2.16, P <
0.00001, I
2 = 49%). Crude mortality was 5.1% for patients
with diabetes and 3.3% for patients without diabetes.
Pooling of the general surgery study data showed a trend
towards higher mortality in diabetic patients (OR 1.21,
95% CI 0.96 to 1.53, P = 0.11, I
2 = 30%).
Most studies reported only crude mortality data or
unadjusted regression analyses. To assess the possible
i n f l u e n c eo fc o n f o u n d e r s ,w ef i r s tl o o k e da tt h ed a t a
derived from five studies that reported unadjusted as well
as adjusted results for in-hospital mortality [26,65,75,
95,121]. Among other parameters, these studies adjusted
for severity of disease. Overall, no difference in effect size
was observed after pooling the unadjusted results (OR
1.06 [95% CI 0.83 to 1.35]) vs. the adjusted results (OR
1.02 [95% CI 0.79 to 1.34]). Introduction of adjusted
instead of unadjusted data in the analysis of in-hospital
mortality did not change the outcome, except for a shift
towards nonsignificance in the analysis of the trauma
patients (1.02 [95% CI 0.93 to 1.13], P = 0.45, I
2 = 0%).
Discussion
Our large meta-analysis shows no significant overall
difference in mortality between critically ill patients
with or without diabetes, except for the subgroup of
cardiac surgery patients. We found a survival disadvan-
tage for patients with diabetes admitted to the ICU
after cardiac surgery. Our sensitivity analyses show
good robustness of the data. If anything, using a fixed
model shifts the outcome from equal survival towards
a small benefit for diabetic patients in the medical and
mixed ICU cohorts for in-hospital mortality, which can
be attributed to the inclusion of two very large cohorts
[26,101]. The clinical consequences are that patients
with diabetes should not be denied access to ICUs on
the basis of their diabetes. It is not possible, however,
to draw conclusions regarding the possible benefits of
tight glycaemia control in patients with diabetes on the
basis of our meta-analysis.
It did not come as a surprise to us to find a negative
impact of diabetes on the survival of cardiac surgery
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ferent from the nondiabetic cardiac surgery population.
As a result of their diabetes, diabetic cardiac surgery
patients are more likely to have three-vessel coronary
artery disease, left main coronary artery stenosis and left
ventricular systolic dysfunction [154,155], all of which
are associated with worse outcomes. Also, these patients
are at increased risk for sternal wound infection, probably
Figure 3 In-hospital mortality. Forest plots showing odds ratios (ORs) and 95% confidence intervals (95% CIs) of hospital mortality risk for
patients with or without diabetes. SE: standard error. IV: inverse variance.
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disease [6,7].
On the other hand, it is remarkable to find no increased
mortality for patients with diabetes in the medical and
mixed ICU patient populations. Patients with diabetes are
known to have a higher chance of developing complica-
tions such as sepsis and acute organ failure when they are
admitted to the ICU [3-5]. These complications are asso-
ciated with mortality, at least in the nondiabetic patient
population. Apparently, diabetes is a risk factor only for
the development of complications, but once acquired, the
mortality risk is equal to or perhaps even lower than that
of nondiabetic patients.
A possible explanation for the relative protection of cri-
tically ill patients with diabetes could lie in the different
effects of stress-induced hyperglycaemia between the two
groups. Hyperglycaemia is common in critically ill
patients, and not only in those with diabetes. It is asso-
ciated with mortality [156], but it has been shown that
patients with diabetes are less affected than nondiabetic
patients by high glucose levels [26,77,157,158]. It might
be that the relative protection from stress-induced hyper-
glycaemia counteracts the increased mortality risk due to
an increased amount of complications. Other mechan-
isms may, of course, contribute [26]. Further studies are
needed to unravel the exact effects of hyperglycaemia in
patients with or without diabetes.
Because of the nature of the included studies, we mainly
show unadjusted results. It might be possible that the
baseline characteristics between patients with or without
diabetes were different, which would influence the out-
come. If there were a difference, it would seem likely that
patients with diabetes would be more severely ill at the
time of admission. Adjusting for severity of illness would
Figure 4 Thirty-day mortality. Forest plots showing odds ratios (ORs) and 95% confidence intervals (95% CIs) of 30-day mortality risk for
patients with or without diabetes. The ‘0’ indicating the number of diabetic or nondiabetic patients means the information was not available. SE:
standard error. IV: inverse variance.
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sis, thus indicating a greater advantage only for patients
with diabetes. This effect is seen in the in-hospital mortal-
ity outcomes among the trauma patient population. It
might be possible that adjustment for severity of disease
decreases the negative effect of diabetes seen in cardiac
surgery patients. However, our results represent the mor-
tality risk of the average patient with or without diabetes,
irrespective of the differences between the populations
associated with diabetes.
There are limitations associated with our meta-analysis.
First, the published data do not allow differentiating type 1
from type 2 diabetes or insulin-treated from non-insulin-
treated diabetes, and it might be possible that there are
differences in outcomes between these groups. Further-
more, incomplete capture of diet-treated or undiagnosed
diabetes in the included studies is likely, as most studies
relied on the use of glucose-lowering drugs. Second, we
could not retrieve mortality data from three studies. It is
unlikely that including these three studies would have
shifted the results to a disadvantage for patients with
diabetes, since the P values for mortality related to the pre-
sence of diabetes in these studies were not significant.
Third, for 90 potentially relevant studies, the full articles
could not be retrieved. These studies comprised a total of
48,263 patients, which would have contributed only 0.39%
to the total population, so we expect that this had little
influence on the outcomes. Fourth, the heterogeneity
among studies was quite large. Fifth, the crude mortality
rates in the three surgical populations were driven by the
studies included: the high mortality rate in the surgical
ICUs is heavily weighted by general surgery studies, whilst
for in-hospital and 30-day mortality figures, the cardiac
surgery studies with much lower mortality rates
dominated.
Conclusions
We show in this meta-analysis that patients with diabetes
who are admitted to medical, mixed and trauma ICUs
have chances of survival similar to those of patients with-
out diabetes. Diabetes significantly increases mortality risk
only in patients admitted after surgery, more specifically
after cardiac surgery, a population with distinct character-
istics of the underlying disease. Further studies are needed
to unravel the pathophysiological mechanisms by which
patients with diabetes seem to be relatively protected in
nonsurgical settings, despite higher complication rates.
Key messages
￿ Patients with diabetes admitted to medical, mixed
and trauma ICUs have chances of survival similar to
those of patients without diabetes.
￿ Patients with diabetes should not be denied access
to ICU facilities on the basis of their diabetes.
￿ T h ep r e s e n c eo fd i a b e t e ss ignificantly increases
mortality risk for patients admitted after cardiac
surgery.
￿ The pathophysiological mechanisms by which
patients with diabetes have equal mortality rates
despite higher complication risks in nonsurgical set-
tings should be a subject of further research.
Additional material
Additional file 1: Characteristics of the 141 studies included in the
meta-analysis of ICU-, hospital- and 30-day mortality of patients
with diabetes admitted to the ICU.
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